BACKGROUND: The prosthetic arteriovenous grafts (AVG) being used increasingly to create hemodialysis access are prone to infections that pose potentially life-threatening infectious and bleeding complications, as well as loss of dialysis access. In this study, we identified the bacteriologic agents of infected AVGs by site swab, blood culture, and prosthesis cultures, and to evaluate the role of microbiological findings in the management of the infection. METHODS: We focused on 51 patients with 53 AVGs operated on in our clinic from January 2006 to December 2009. An infected AVG was identified by clinical, ultrasound, and microbiological findings. Sensitivity to antibiotics was determined for all bacterial strains. Isolates were identified by pulsed-field gel electrophoresis (PFGE) of bacterial DNA. In a few cases, positron emission tomography-computed tomography (PET-CT) examination was performed. RESULTS: Strains of Staphylococcus spp., especially S. aureus, were the most frequent cause of infected AVG. All S. aureus strains were sensitive to methicillin. With the exception of a single case, isolates obtained simultaneously from the skin site and the vascular prosthesis were identical genetically. CONCLUSIONS: Our results suggest that bacterial infectious agents detected in site swab, blood, or graft culture confirm a suspicion of AVG infection. A PET-CT examination can provide confirmation. The combination of microbiologic and radionuclide findings can improve the management of the AVG infection, but surgery remains essential.

2nd Surgery Clinic Palacky University Olomouc Olomouc Czech Republic

See more in PubMed

National Kidney Foundation. Kidney Disease Outcome Quality Initiative (NKF K/DOQI) Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis. 2001;37:137–181. PubMed

Ethier J. Mendelssohn DC. Elder SJ, et al. Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219–3226. PubMed PMC

Berardinelli L. Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg. 2006;32:203–211. PubMed

Schild AF. Perez E. Gillaspie E, et al. Arteriovenous fistulae vs arteriovenous grafts: A retrospective review of 1,700 consecutive vascular access cases. J Vasc Access. 2008;9:231–235. PubMed

Young EW. Dykstra DM. Goodkin DA, et al. Hemodialysis vascular access preferences at outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Kidney Int. 2002;61:2266–2271. PubMed

Vilhelmi M. Haverich A. Material used for hemodialysis vascular access: Current strategies and a call to action. Graft. 2003;6:6–15.

Sarnak MJ. Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758–1764. PubMed

Butterly DW. Schwab SJ. Dialysis access infection. Curr Opin Nephrol Hypertens. 2000;9:631–635. PubMed

Lafrance JP. Rahme E. Lelorier J. Iqbal S. Vascular access related infections: Definitions, incidence rates, and risk factors. Am J. Kidney Dis. 2008;52:982–983. PubMed

Minga TE. Flanagan KH. Allon M. Clinical consequences of infected arteriovenous grafts in hemodilaysis patients. Am J Kidney Dis. 2001;38:975–978. PubMed

Ryan SV. Calligaro KD. Scharff J. Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–78. PubMed

Lentino JR. Baddour LM. Wray M, et al. Staphylococcus aureus and other bacteremias in hemodialysis patients: Antibiotic therapy and surgical removal of access site. Infection. 2000;28:355–360. PubMed

Engemann JJ. Friedman JY. Reed SD, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005;26:534–539. PubMed

Troidle L. Eisen T. Pacelli L. Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int. 2007;11:72–75. PubMed

Shurland S. Zhan M. Bradham DD. Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistent and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273–279. PubMed

Klevens RM. Morrison MA. Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:763–771. PubMed

Shorr AF. Epidemiology of staphylococcal resistence. Clin Infect Dis. 2007;45:171–176. PubMed

Berns JS. Infection with antimicrobial-resistent microorganisms in dialysis patients. Semin Dial. 2003;16:30–37. PubMed

Hadley AC. Karchmer TB. Russell GB, et al. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol. 2007;27:352–359. PubMed

Barbosa D. Lima L. Silbert S, et al. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistent Enterococcus among patients on dialysis. Am J Kidney Dis. 2004;44:337–343. PubMed

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. 2009;29:M100–S119.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) www.eucast.org/ www.eucast.org/ PubMed

Oliviera DC. de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155–2161. PubMed PMC

Sauer P. Sila J. Stosova T, et al. Prevalence of genes encoding extracellular factors among methicillin-resistant Staphylococcus aureus isolates from the University Hospital, Olomouc, Czech Republic. J Med Microbiol. 2008;57:403–410. PubMed

Shi ZY. Liu PY. Lau YJ, et al. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis. J Clin Microbiol. 1996;34:2784–2790. PubMed PMC

US Renal Data System. 2007 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2007.

Lawrence PF. Dries DJ. Alazraki N. Albo D., Jr Indium-111-labeled leukocyte scanning for detection of prosthetic vascular graft infection. J Vasc Surg. 1985;2:165–173. PubMed

Taylor G. Gravel D. Johnston L, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32:155–160. PubMed

Nahrstedt U. Keller E. Perigraftreaktionen bei Kunststoffprothesen zur Dialyse. In: von Sommoggy S, editor; Kistler D, editor. Hämodialyse Shuntchirurgie. Berlin: Blackwell Wissenschaft; 1993. pp. 141–146.

Carlos MG. Juliana R. Matilde N, et al. Hidden clotted vascular access infection diagnosed by fluorodeoxyglucose positron emission tomography. Nephrology. 2008;13:264–265. PubMed

Stevenson KB. Hannah EL. Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF–DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–555. PubMed

Hoen B. Paul-Dauphin A. Hestin D. Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic dialysis patients. J Am Soc Nephrol. 1998;9:869–876. PubMed

Kolar M. Latal T. The implementation of a practical antibiotic policy in the Czech Republic. Infect Control Hosp Epidemiol. 1999;20:440–443. PubMed